Moreover, our group also found recently that high POU2F3 expression is associated with improved survival outcomes, whereas elevated ASCL1 expression is an independent negative prognosticator in surgically treated SCLC patients,9 highlighting the prognostic relevance of SCLC subgroups. The gene discussed is POU2F3; the disease is small cell lung carcinoma.